Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Read Article
News
2024
2023
Archive
Search news articles
September 15, 2016
HOMOLOGY MEDICINES ACQUIRES LICENSE TO NOVEL AAV TECHNOLOGY TO DEVELOP TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
September 8, 2016
CHRONO THERAPEUTICS RAISES $47.6 MILLION IN SERIES B FINANCING TO ADVANCE ITS CLINICAL PLATFORM FOR PERSONALIZED DRUG THERAPY
September 1, 2016
ACHAOGEN COMPLETES PATIENT ENROLLMENT IN PHASE 3 EPIC CLINICAL TRIAL OF PLAZOMICIN
August 31, 2016
AUDENTES THERAPEUTICS REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
August 18, 2016
SPYRYX BIOSCIENCES EXPANDS EXECUTIVE TEAM, APPOINTS PULMONARY INDUSTRY LEADER, ALISTAIR WHEELER, MD, MFPM AS CHIEF MEDICAL OFFICER
August 17, 2016
AUDENTES THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN THE INCEPTUS CLINICAL ASSESSMENT STUDY OF XLMTM
August 11, 2016
CIDARA REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
August 9, 2016
CIDARA THERAPEUTICS ANNOUNCES PRESENTATIONS ADDRESSING VULVOVAGINAL CANDIDIASIS AT UPCOMING IDSOG ANNUAL MEETING
August 8, 2016
CLEAVE BIOSCIENCES RAISES $37 MILLION SERIES B FINANCING
July 27, 2016
MILLENDO THERAPEUTICS ANNOUNCES PUBLICATION OF POSITIVE PHASE 2A DATA FOR MLE4901 FOR THE TREATMENT OF POLYCYSTIC OVARY SYNDROME
« Previous Page
1
…
91
92
93
94
95
…
118
Next Page »